Disease Monitoring In Multiple Myeloma

被引：1

作者：

Hillengass, Jens ^{[1
]}

Martin, Tom ^{[2
]}

Puig, Noemi ^{[3
]}

Paiva, Bruno ^{[4
]}

Usmani, Saad ^{[5
]}

Kumar, Shaji ^{[6
]}

San-Miguel, Jesus ^{[4
,7
]}

机构：

[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[2] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[3] Dept Hematol Salamanca, Salamanca, Spain

[4] Clin Univ Navarra, CCUN, CIMA, CIBERONC,IDISNA, Pamplona, Spain

[5] Levine Canc Inst Atrium Hlth, Charlotte, NC USA

[6] Mayo Clin, Dept Hematol, Rochester, MN USA

[7] Clin Univ Navarra, Pio 12 Ave 36, Pamplona 31008, Spain

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷 / 04期

关键词：

POSITRON-EMISSION-TOMOGRAPHY; MINIMAL RESIDUAL DISEASE; STEM-CELL TRANSPLANTATION; IMAGING TECHNIQUES; COMPLETE RESPONSE; SURVIVAL; DIAGNOSIS; THERAPY; CORRELATE; PATTERNS;

D O I：

10.1016/j.clml.2023.01.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：244 / 248

页数：5

共 50 条

[31] The Prevalence and Management of Multiple Myeloma-Induced Kidney Disease in China
Shi, Hao
Chen, Zijin
Xie, Jingyuan
Chen, Nan
KIDNEY DISEASES, 2016, 1 (04) : 235 - 240
[32] Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives
Mina, Roberto
Oliva, Stefania
Boccadoro, Mario
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 16
[33] Prognostic and predictive biomarker developments in multiple myeloma
Wallington-Beddoe, Craig T.
Mynott, Rachel L.
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[34] Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference
McCudden, Christopher
Axel, Amy E.
Slaets, Dominique
Dejoie, Thomas
Clemens, Pamela L.
Frans, Sandy
Bald, Jaime
Plesner, Torben
Jacobs, Joannes F. M.
van de Donk, Niels W. C. J.
Moreau, Philippe
Schecter, Jordan M.
Ahmadi, Tahamtan
Sasser, A. Kate
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (06) : 1095 - 1104
[35] Immunoglobulin D Multiple Myeloma: A Rare Variant
MacDougall, Kira N.
Niazi, Muhammad Rafay Khan
Rehan, Maryam
Xue, Wei
Dhar, Meekoo
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
[36] Multiple myeloma, immunotherapy and minimal residual disease
Kusenda, J.
Kovarikova, A.
NEOPLASMA, 2016, 63 (05) : 651 - 658
[37] Can multiple myeloma become a curable disease?
San-Miguel, Jesus F.
Mateos, Maria-Victoria
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (09): : 1246 - 1248
[38] Standardisation of minimal residual disease in multiple myeloma
Innao, V.
Allegra, A.
Russo, S.
Gerace, D.
Vaddinelli, D.
Alonci, A.
Allegra, A. G.
Musolino, C.
EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
[39] Advances in the treatment of extramedullary disease in multiple myeloma
Li, Yating
Sun, Zhengxu
Qu, Xiaoyan
TRANSLATIONAL ONCOLOGY, 2022, 22
[40] Bendamustine in multiple myeloma
Gentile, Massimo
Vigna, Ernesto
Recchia, Anna Grazia
Morabito, Lucio
Mendicino, Francesco
Giagnuolo, Giovanna
Morabito, Fortunato
EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (05) : 377 - 388

← 1 2 3 4 5 →